2017
DOI: 10.5958/0974-9357.2017.00089.7
|View full text |Cite
|
Sign up to set email alerts
|

Antiphospholipid Antibody Syndrome (Aplas)-A Case Report

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
10
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(10 citation statements)
references
References 0 publications
0
10
0
Order By: Relevance
“…1,2 APS often occurs as a primary condition but can also present with other systemic autoimmune diseases, such as systemic lupus erythematosus (SLE). 1,3,4 The key signs of APS include venous thromboembolism (VTE), myocardial infarction (MI), stroke, pregnancy complications (such as miscarriage and clotting), and fetal death. 1,2 People diagnosed with APS have a greater risk of cardiovascular events than individuals with traditional cardiovascular risk factors.…”
Section: Antiphospholipid Syndrome: Signs and Nursing Interventionsmentioning
confidence: 99%
See 4 more Smart Citations
“…1,2 APS often occurs as a primary condition but can also present with other systemic autoimmune diseases, such as systemic lupus erythematosus (SLE). 1,3,4 The key signs of APS include venous thromboembolism (VTE), myocardial infarction (MI), stroke, pregnancy complications (such as miscarriage and clotting), and fetal death. 1,2 People diagnosed with APS have a greater risk of cardiovascular events than individuals with traditional cardiovascular risk factors.…”
Section: Antiphospholipid Syndrome: Signs and Nursing Interventionsmentioning
confidence: 99%
“…APS occurs when the body's immune system creates aPLs that attack coagulation factors or proteins bound to phospholipids (prothrombin, protein C, protein S, and annexin), which are found throughout the body. 4 These aPLs are produced by B cells and bind to the anionic surfaces of cell membranes. 8 The three primary classes of antibodies associated with APS are anticardiolipin (aCL) antibodies, lupus anticoagulants (LACs), and anti-beta-2 glycoprotein I antibodies (anti-b2GPI).…”
Section: Pathogenesismentioning
confidence: 99%
See 3 more Smart Citations